Image

The New Combined PET-MR System NextGen PET-MR With Syngo MR XA80A: Evaluation of Diagnostic Image Quality and Usability (Software and Hardware) in the Clinical Setting.

The New Combined PET-MR System NextGen PET-MR With Syngo MR XA80A: Evaluation of Diagnostic Image Quality and Usability (Software and Hardware) in the Clinical Setting.

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This clinical investigation is used to evaluate the novel PET-MR scanner and it is a clinical investigation under MDR.

The focus is on the evaluation of the diagnostic image quality in a clinical setting, considering the speed of the examination and the new functionalities to minimize the patient's lying times. Based on the assessment, the defined protocols and measurement sequences are further improved as necessary to optimize the clinical value of the sequences and user interface components.

Eligibility

Inclusion Criteria:

  • Adult test subjects for whom a PET-MR examination is indicated and will be performed, or
  • Test subjects for whom a PET-CT examination is indicated and will be performed
  • Test subjects of legal age who have given their written informed consent to participate in the clinical investigation
  • Written consent of the test subject to be informed in the event of suspected clinically relevant incidental findings
  • Written consent to the disclosure of a clinically relevant incidental finding to a subsequent physician (release from the duty of confidentiality)
  • The test subject´s written consent that the recorded image data may be made available to Siemens Healthcare A/S in pseudonymized form
  • Test subjects whose weight does not exceed the permissible weight limit of the patient table (200 kg).

Exclusion Criteria:

  • Metal in and on the body that causes stress to the test subject during an examination in the FoV of the combined PET-MR system
  • All pacemakers and other implants
  • Pregnancy: The exclusion of test subjects of childbearing potential is carried out based on a positive pregnancy test
  • Test subjects who indicate an increased sensitivity to loud noises
  • Test subjects who are incapable of giving consent.

Study details
    The Evaluation of a New MD - Combined PET-MR System

NCT06666387

Siemens Healthcare A/S

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.